Stay ahead of the curve with curated content from across the advanced therapies industry. From breaking news and regulatory updates to expert interviews and event highlights, Phacilitate’s Insights & Resources hub is your go-to destination for thought leadership in cell and gene therapy.
-
)
Get an exclusive first look at what’s in store for Advanced Therapies Europe 2025. This live webinar will explore the key themes, sessions, and standout experiences that will define this year’s event ... -
)
This case study showcases the successful expansion of mesenchymal stem cells (MSCs) using Rooster Bio's xeno-free MSC platform in Univercells Technologies' scale-X fixed-bed bioreactor. The collaborat ... -
)
This webinar examined how to scale gene-enabled cell therapies, with emphasis on allogeneic programs moving toward commercial manufacture. The panel covered regulatory strategy, comparability, manufac ... -
)
Meeting the Challenge of a Pandemic Response: How to Mitigate Risk When Scaling Up GMP Manufacturing
This legacy webinar distills the operational blueprint behind the Oxford–AstraZeneca COVID-19 program: leveraging a mature adenoviral (ChAdOx1) platform, validated scale-down models, and a centrally g ... -
)
In partnership with Buchanan Ingersoll & Rooney, this session provides a comprehensive overview of FDA responsibilities for cell therapy companies. Speakers detail how the Agency categorizes HCT/Ps; w ... -
)
This webinar shows how to turn fragmented ATMP data into faster, better decisions. Speakers from Körber detail automated contextualization, phase and KPI extraction, integrated process modeling, and d ... -
)
AI is a broad umbrella, from rule-based systems through machine learning to generative models. In CGT, the traction is with applied AI that speeds process decisions, tightens control, and shortens ite ...